SETA BioMedicals was founded in 2008 with the aim to develop, produce and commercialize reliable, proprietary, high-quality fluorescence products (fluorescence detection reagents) for the biomedical fields and to enter into strategic alliances with corporate partners.

There is a demand for novel, fluorescent reagents, in particular for new, emerging fluorescence applications (annual market for fluorescent reagents is in the order of over 1 billion and growing 20% annually) and some of the latest product developments of SETA BioMedicals are addressing this need.